Home Innovation That Matters

Innovation That Matters

It’s in the ‘Genes’: The Quest to Develop a Cure for Rare, Genetic Diseases

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) “We always felt like gene therapy was coming back, and it sure did. This technology represented a great way for us to come together as a team again to deliver the promise of gene editing...

Partner in News: TruTag Uses ‘Edible Barcodes’ in Fight against Counterfeit Drug Trade

By Brian Mastroianni Published July 09, 2015 FoxNews.com Who knew that the answer to fighting the trillion-dollar global counterfeit drug problem rested in a particle the size of a speck of dust? At least that’s what entrepreneur Dr. Hank Wuh is counting on with TruTag Technologies,...

Harnessing Science for the Most Neglected Diseases

By Rich Soll, VP of Research Service Division at WuXi AppTec (@richsollwx)  “Some of these diseases are rapidly fatal, cause huge loss of life, and have a huge impact on people’s lives. Often these are diseases that have attracted little research and attention and certainly...

First Crystal Structure of Human GLUT1 Solved

An article published in the prestigious Nature magazine this summer by a group led by one of a 2012 recipient of WuXi Life Science and Chemistry Awards, Dr. Nieng Yan of Tsinghua University, made a great contribution toward the understanding of GLUT1 functions and...

BCX4161, a Promising New Orally Administered Drug for the Rare and Genetic Disorder Hereditary Angioedema, Received Fast Track Status from the FDA

BioCryst Pharmaceuticals, Inc., a small pharmaceutical company headquartered in Durham, North Carolina announced on January 26 that one of the drugs in the company’s pipeline, BCX4161 has been granted fast track status by the FDA. BCX4161 is a novel and selective inhibitor of plasma kallikrein...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease...

We are thrilled about WuXi NextCODE's contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood...